CVS Health Corporation $CVS Shares Acquired by DNB Asset Management AS

DNB Asset Management AS lifted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 66.7% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 379,890 shares of the pharmacy operator’s stock after acquiring an additional 151,934 shares during the period. DNB Asset Management AS’s holdings in CVS Health were worth $28,640,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of CVS. Vanguard Group Inc. grew its position in CVS Health by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock worth $8,305,132,000 after purchasing an additional 2,063,737 shares during the last quarter. State Street Corp lifted its stake in shares of CVS Health by 1.4% during the second quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock worth $4,055,237,000 after buying an additional 800,414 shares during the period. Geode Capital Management LLC grew its holdings in shares of CVS Health by 2.4% during the second quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock valued at $1,966,083,000 after buying an additional 675,824 shares during the last quarter. Invesco Ltd. increased its position in shares of CVS Health by 15.3% in the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after acquiring an additional 3,118,626 shares during the period. Finally, Norges Bank purchased a new position in CVS Health in the 2nd quarter worth $1,358,698,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have weighed in on CVS. Barclays boosted their price target on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $91.00 target price on shares of CVS Health in a research report on Tuesday, January 6th. Cantor Fitzgerald reissued an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. The Goldman Sachs Group upped their price objective on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Finally, Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Nineteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.91.

CVS Health Trading Up 2.2%

CVS Health stock opened at $79.74 on Friday. The firm has a market cap of $101.44 billion, a PE ratio of 57.78, a P/E/G ratio of 0.81 and a beta of 0.50. CVS Health Corporation has a 12 month low of $58.35 and a 12 month high of $85.15. The stock’s 50 day simple moving average is $78.39 and its two-hundred day simple moving average is $77.13. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business’s revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.3%. The ex-dividend date was Thursday, January 22nd. CVS Health’s payout ratio is currently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.